Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Measuring outcomes: why now?

D L Witte1

  • 1Laboratory Control, Ltd., Ottumwa, IA 52501, USA.

Clinical Chemistry
|May 1, 1995
PubMed
Summary
This summary is machine-generated.

The American healthcare system faces significant changes driven by cost, quality, and access concerns. Laboratories must shift focus from providing tests to demonstrating value through measurable patient outcomes for future success.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An evaluation of analytic goals for assays of drugs: a College of American Pathologists Therapeutic Drug Monitoring Survey Study.

Archives of pathology & laboratory medicine·2001
Same author

Sources of variability: a College of American Pathologists Therapeutic Drug Monitoring study.

Archives of pathology & laboratory medicine·2001
Same author

Redesigned proficiency testing materials improve survey outcomes for prostate-specific antigen. A College of American Pathologists Ligand Assay Survey tool.

Archives of pathology & laboratory medicine·2000
Same author

Frequency of unacceptable results in point-of-care testing.

Archives of pathology & laboratory medicine·1999
Same author

Strategies to increase detection of hemochromatosis.

Annals of internal medicine·1998
Same author

College of American Pathologists Conference XXXI on laboratory monitoring of anticoagulant therapy: laboratory monitoring of unfractionated heparin therapy.

Archives of pathology & laboratory medicine·1998
Same journal

Interlaboratory Comparison of a Glucagon and Oxyntomodulin Immuno-LC-MS/MS Assay: Implications for Diabetes Research.

Clinical chemistry·2026
Same journal

Comparison of Information-Dependent Acquisition and Sequential Window Acquisition of All Theoretical Mass Spectra for Untargeted Drug Testing on a Linear Ion Trap-Pulsing Quadrupole-Time of Flight Mass Spectrometer.

Clinical chemistry·2026
Same journal

Patterns of One-Year Change in HbA1c and Continuous Glucose Monitoring (CGM) Metrics in Older Adults with Type 2 Diabetes.

Clinical chemistry·2026
Same journal

TSH Pediatric Reference Intervals: Lack of CALIPER Applicability to US-Based Populations.

Clinical chemistry·2026
Same journal

Rapid Detection of Hemoglobinopathy Variants Using One-Step Library Preparation and Nanopore Sequencing.

Clinical chemistry·2026
Same journal

Editor's Note: Circulating Proteolytic Products of Carboxypeptidase N for Early Detection of Breast Cancer.

Clinical chemistry·2026
See all related articles

Area of Science:

  • Healthcare Management
  • Health Economics
  • Laboratory Medicine

Background:

  • The American healthcare paradigm is undergoing intense scrutiny, driven by government reform, managed care, and evolving patient/provider expectations.
  • Key concerns include quality, access, and cost, with a notable shift towards prioritizing cost containment.
  • Uncertainty in 'appropriateness' research creates an accountability gap between payors and providers.

Purpose of the Study:

  • To analyze the transformative pressures on the healthcare system and their impact on various stakeholders.
  • To explore the evolving role of laboratories within the changing healthcare landscape.
  • To identify challenges and opportunities for laboratories in demonstrating value and achieving sustainable profit models.

Main Methods:

Related Experiment Videos

  • Qualitative analysis of current trends in healthcare policy, economics, and provider-payor dynamics.
  • Examination of the shift from disease-centric to healthcare-centric models.
  • Review of the changing definitions of value and profit within healthcare organizations.

Main Results:

  • Healthcare is transitioning towards consumer-centricity, collaboration, and accountability, moving away from provider autonomy.
  • Laboratories face a paradigm shift, expected to deliver outcomes rather than just tests, with income tied to covered lives, not volume.
  • Profit models are evolving from 'piecework and efficiency' to 'prevention profit,' necessitating robust outcomes measurement.

Conclusions:

  • Effective 'outcomes' measurement is crucial for reducing uncertainty and demonstrating laboratory value in care processes.
  • Laboratories must clarify their contribution to value by defining the information gained from each test and its role in preventing future services.
  • Adapting to these changes requires a strategic focus on value-based care and measurable health outcomes.